Free tool
Dividend paying stocks
We cover 55 companies that currently pay a dividend. The median market value in the group is $21.77B. Across the group, the median move over the past trading day is +0.55%. 49% of the 53 with a 200-day average trade above it. Price change over the past year runs from −33.2% to +34.9% across the middle 80 percent of the group, with a median of +1.7%.
Other lists in this group
Table
55 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.76B | Large cap | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +32.17% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| H6D0.DE | Haleon plc | $44.85B | Large cap | +5.39% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% |
| PHI1.DE | Koninklijke Philips N.V. | $26.37B | Large cap | +3.22% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +25.88% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| SN.L | Smith & Nephew plc | $12.18B | Large cap | −22.42% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% |
| OMDA.OL | Omda AS | $81.21M | Micro cap | −23.98% |
| GENT.OL | Gentian Diagnostics ASA | $65.68M | Micro cap | −30.41% |
| AJ91.DE | DocCheck AG | $64.48M | Micro cap | −9.92% |
| HVO.L | hVIVO plc | $59.87M | Micro cap | −35.00% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| SVS.MI | Svas Biosana S.p.A. | $50.68M | Micro cap | +0.98% |
| M3V.DE | MeVis Medical Solutions AG | $50.50M | Micro cap | −0.42% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| X74.F | I.M.D. International Medical Devices S.p.A. | $20.60M | Micro cap | −22.17% |
| GME.DE | Geratherm Medical AG | $15.65M | Micro cap | −16.50% |
| PHR.WA | Pharmena S.A. | $9.45M | Micro cap | −8.72% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.